News in the Life Sciences Industry

CANTON, Mass. and NEW YORK, Dec. 10, 2018 /PRNewswire/ -- Organogenesis Holdings Inc. ("ORGO"), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care, Surgical and Sports Medicine markets, today announced... Read more ››

NEW YORK, Dec. 10, 2018 /PRNewswire/ -- US In Vitro Diagnostics Industry 2019-2023: Supplier Shares by Test, Segment Volume and Sales Forecasts, Instrumentation Review, Opportunities for Suppliers

NEW YORK, Dec. 10, 2018 /PRNewswire/ -- 2019-2023 Orthopedics Market Segment Forecasts, Supplier Strategies, Marketing Tactics

This report provides a worldwide strategic overview of the orthopedics market, including:

NEW YORK, Dec. 10, 2018 /PRNewswire/ --Executive Summary

NEW YORK, Dec. 10, 2018 /PRNewswire/ -- 2019-2023 Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

NEW YORK, Dec. 10, 2018 /PRNewswire/ -- 2019-2023 Diagnostic Testing in Physician Offices and Group Practices: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

PALO ALTO, Calif., Dec. 10, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced that it will report results for the first quarter of fiscal year 2019 after market close on Wednesday, January 23, 2019. The news release will be followed by a teleconference available to all interested at 1:30... Read more ››

NEW YORK, Dec. 10, 2018 /PRNewswire/ -- Report Scope

SAN DIEGO, Dec. 10, 2018 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, today announced the appointment of Maya Martinez-Davis to the Company's Board of Directors, effective immediately.

THOUSAND OAKS, Calif. and SAN FRANCISCO, Dec. 10, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and the Lazarex Cancer Foundation, a non-profit organization focused on improving patient access to cancer clinical trials, today announced that they have teamed up to support more equitable access to clinical... Read more ››

NEWARK, N.J., Dec. 10, 2018 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE American: RFL), reported revenue of $1.1 million and a loss per share of $0.04 for the first quarter of its 2019 fiscal year, the three months ended October 31, 2018.

NEW YORK, Dec. 10, 2018 /PRNewswire/ --

SILVER SPRING, Md., Dec. 10, 2018 /PRNewswire/ -- Advancing medical device safety remains a top priority of the U.S. Food and Drug Administration. This means we are committed to communicating when new, relevant information becomes available about device safety risks, to ensure doctors and patients... Read more ››